Jazmin Duque
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jazmin Duque has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Gideon O. Emukule
Influenza Division, US Centers for Disease Control and Prevention, Nairobi P.O. Box 606-00621, Kenya
1 shared publication - Irene W. Ndigirigi
Ministry of Health, Government of Kenya, Nyeri, Nairobi, Kenya
1 shared publication - John Paget
Netherlands institute for health services research (NIVEL) Utrecht The Netherlands
1 shared publication - Joshua A. Mott
National Center for Immunization and Respiratory Diseases Centers for Disease Control and Prevention Hanoi Vietnam
1 shared publication - Kabura Wamburu
Kenya Medical Research Institute, Kisumu, Nairobi, Kenya
1 shared publication - Koos van der Velden
Academic Collaborative Centre AMPHI, Department of Primary and Community Care, Radboud University Medical Centre, 6500 HB Nijmegen, The Netherlands
1 shared publication
Latest Publications
- Open Access
- 10 May 2019
- Published by Springer Nature in BMC Public Health
- Vol. 19 (S3) , 1-10
The cost of influenza-associated hospitalizations and outpatient visits in Kenya
We estimated the cost-per-episode and the annual economic burden associated with influenza in Kenya. From July 2013–August 2014, we recruited patients with severe acute respiratory illness (SARI) or influenza-like illness (ILI) associated with laboratory-confirmed influenza from 5 health facilities. A structured questionnaire was used to collect direct costs (medications, laboratory investigations, hospital bed fees, hospital management costs, transportation) and indirect costs (productivity losses) associated with an episode of influenza. We used published incidence of laboratory-confirmed influenza associated with SARI and ILI, and the national population census data from 2014, to estimate the annual national number of influenza-associated hospitalizations and outpatient visits and calculated the annual economic burden by multiplying cases by the mean cost. We enrolled 275 patients (105 inpatients and 170 outpatients). The mean cost-per-episode of influenza was US$117.86 (standard deviation [SD], 88.04) among inpatients; US$114.25 (SD, 90.03) for children < 5 years, and US$137.45 (SD, 76.24) for persons aged ≥5 years. Among outpatients, the mean cost-per-episode of influenza was US$19.82 (SD, 27.29); US$21.49 (SD, 31.42) for children < 5 years, and US$16.79 (SD, 17.30) for persons aged ≥5 years. National annual influenza-associated cost estimates ranged from US$2.96–5.37 million for inpatients and US$5.96–26.35 million for outpatients. Our findings highlight influenza as causing substantial economic burden in Kenya. Further studies may be warranted to assess the potential benefit of targeted influenza vaccination strategies.,
- 10 May 2019
- Published by Springer Nature in BMC Public Health
- Vol. 19 (S3) , 1-10
Open AccessThe cost of influenza-associated hospitalizations and outpatient visits in Kenya
We estimated the cost-per-episode and the annual economic burden associated with influenza in Kenya. From July 2013–August 2014, we recruited patients with severe acute respiratory illness (SARI) or influenza-like illness (ILI) associated with laboratory-confirmed influenza from 5 health facilities. A structured questionnaire was used to collect direct costs (medications, laboratory investigations, hospital bed fees, hospital management costs, transportation) and indirect costs (productivity losses) associated with an episode of influenza. We used published incidence of laboratory-confirmed influenza associated with SARI and ILI, and the national population census data from 2014, to estimate the annual national number of influenza-associated hospitalizations and outpatient visits and calculated the annual economic burden by multiplying cases by the mean cost. We enrolled 275 patients (105 inpatients and 170 outpatients). The mean cost-per-episode of influenza was US$117.86 (standard deviation [SD], 88.04) among inpatients; US$114.25 (SD, 90.03) for children < 5 years, and US$137.45 (SD, 76.24) for persons aged ≥5 years. Among outpatients, the mean cost-per-episode of influenza was US$19.82 (SD, 27.29); US$21.49 (SD, 31.42) for children < 5 years, and US$16.79 (SD, 17.30) for persons aged ≥5 years. National annual influenza-associated cost estimates ranged from US$2.96–5.37 million for inpatients and US$5.96–26.35 million for outpatients. Our findings highlight influenza as causing substantial economic burden in Kenya. Further studies may be warranted to assess the potential benefit of targeted influenza vaccination strategies.,